药物详细合成路线
| Name | Lisdexamfetamine Mesilate;L-Lysine-d-amphetamine dimesylate;NRP-104;SPD-489;Vyvanse | | Chemical Name | 2(S),6-Diamino-N-[1(S)-methyl-2-phenylethyl]hexanamide bis(methanesulfonate)
N1-[1(S)-Methyl-2-phenylethyl]-L-lysinamide bis(methanesulfonate) | | CAS | 608137-33-3 | | Related CAS | 608137-32-2 (free base), 819871-04-0 (hydrochloride) | | Formula | C17H33N3O7S2 | | Structure |  | | Formula Weight | 455.5919 | | Stage | 上市-2007 | | Company | New River Pharmaceuticals, Inc. (US); developed in collaboration with Shire plc (UK, US) | | Activity/Mechanism | Treatment of Attention Deficit Hyperactivity Disorder | | Syn. Route | 1 |
来源:药化网
作者:药化小编
摘要:本文合成路线介绍的是药物中文名甲磺酸赖氨酸安非他命；英文名Lisdexamfetamine Mesilate;L-Lysine-d-amphetamine dimesylate;NRP-104;SPD-489;Vyvanse；CAS[608137-33-3]
|
